Literature DB >> 8601662

Treatment of bullous pemphigoid with dapsone: retrospective study of thirty-six cases.

F Bouscarat1, O Chosidow, C Picard-Dahan, V Sakiz, B Crickx, C Prost, J C Roujeau, J Revuz, S Belaich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8601662     DOI： 10.1016/s0190-9622(96)80085-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  8 in total

1.  [Bullous pemphigoid: a new look at a well-known disease].

Authors:  G Balakirski; H F Merk; M Megahed
Journal:  Hautarzt       Date:  2014-12       Impact factor: 0.751

Review 2.  A comprehensive insight into the anti-inflammatory properties of dapsone.

Authors:  Mina Khalilzadeh; Maryam Shayan; Sina Jourian; Mohammad Rahimi; Mohammad Sheibani; Ahmad Reza Dehpour
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-09-20       Impact factor: 3.195

3.  How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey.

Authors:  Marine Guignant; Billal Tedbirt; Dedee F Murrell; Masayuki Amagai; Valeria Aoki; Johannes Bauer; Giuseppe Ciancinni; Donna Culton; Maryam Daneshpazhooh; Dipankar De; Janet Fairley; Russell Hall; Soo-Chan Kim; Neil J Korman; Cezary Kowalewski; Daniel Mimouni; Aikaterini Patsatsi; Vivien Hebert; Marwah Adly Mohamed Saleh; Enno Schmidt; Eli Sprecher; Soner Uzun; Vanessa Venning; Victoria P Werth; Detlef Zillikens; Pascal Joly
Journal:  JID Innov       Date:  2022-04-12

Review 4.  Management of autoimmune skin disorders in the elderly.

Authors:  Wei Jing Loo; Nigel P Burrows
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

5.  Therapy of autoimmune bullous diseases.

Authors:  Diya F Mutasim
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

6.  Dapsone in the Management of Pemphigus and Pemphigoid: Rediscovery of its Long-Lost Efficacy.

Authors:  Salim Alkeraye; Lama R AlZamil; Suha Alenazi
Journal:  Cureus       Date:  2020-06-24

Review 7.  Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: A systematic review.

Authors:  Faith A P Zeng; Anna Wilson; Tabrez Sheriff; Dedee F Murrell
Journal:  JAAD Int       Date:  2022-08-07

Review 8.  A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management.

Authors:  Adriana T Lopez; Larisa Geskin
Journal:  Oncologist       Date:  2018-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.